Viewing nowCombinationDouble Proj 5/80mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Joah Pharmaceutical Co., Ltd.

MFDS item code 201701498 · Approved 2017.03.29 · Insurance code 644603630
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Administration of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients under 18 years of age.
This drug can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, therefore it should be stopped immediately upon confirmation of pregnancy. Individuals who are allergic to this drug or similar medications, pregnant or nursing women, and patients with severe kidney or liver dysfunction should not take this medication. Patients with sodium or fluid depletion should stabilize their condition before taking this medication, and should be carefully monitored for the occurrence of hypotension after starting treatment. Patients with hyperkalemia should frequently check potassium levels when taking this medication with potassium supplements or medications that may increase potassium levels. Patients with renal artery stenosis or those who have recently had a kidney transplant should use this medication with caution due to the risk of worsening kidney function. If symptoms of angioedema occur, the medication should be stopped immediately and not be reused. Patients who have heart failure or have had a myocardial infarction should regularly evaluate kidney function while taking this medication and be cautious as pulmonary edema and other side effects may occur. Patients with acute myocardial infarction or aortic stenosis should also be cautious when taking this medication. When taken with ACE inhibitors, aliskiren, and similar drugs, there is an increased risk of hypotension, hyperkalemia, and worsening kidney function, so co-administration should be avoided or closely monitored. Dizziness or fatigue may occur when driving or operating machinery, so caution is needed. In case of overdose, hypotension or cardiac-related side effects may occur, and immediate medical assistance should be sought. This drug is not recommended for pediatric patients under 18 years of age due to insufficient data on safety and efficacy. Elderly patients can take the same doses as the general adult population, but should follow a doctor's guidance. During treatment, regular checks of blood pressure, kidney function, electrolyte levels, etc. are necessary, and immediate consultation with a physician is advised if any abnormalities arise.
Pharyngitis, influenza, hypersensitivity, visual disturbance, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the pharynx and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, lumbago, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, presacral edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroirritability, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This ensures the drug's efficacy and safety over time.
Dark yellow round film-coated tablets
28 tablets (14 tablets/Alu-Alu X 2), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Joah Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.